We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
The American Association of Clinical Endocrinologists recently announced to its members that after careful consideration, the organization does not endorse the new guidelines on the management of obesity recently published by the American Heart Association, American College of Cardiology and The Obesity Society.
“There are multiple reasons for this decision, including, principally, the incompatibility of these new guidelines with our existing guidelines. Additionally, there are questions and concerns regarding the scientific basis for these new guidelines and the populations of patients at risk from disease who are underserved or ill-considered in these new strategies,” AACE wrote in the statement.
AACE also disagrees with the notion of removing LDL goals because statin therapy alone is insufficient for all at-risk patients, according to the statement.
“A considerable number of high-risk patients with multiple risk factors, diabetes, and established coronary disease do not attain adequate reductions in LDL cholesterol and other lipid abnormalities without further therapies in addition to statins,” AACE wrote.
It recommends that AACE members continue to refer to AACE guidelines and position statements on lipids and obesity for decision-making practices.
This article is more than 5 years old. Information may no longer be current.